Histone deacetylase 1 (HDAC1) is a nuclear enzyme involved in transcriptional repression. We detected cytosolic HDAC1 in damaged axons in brains of humans with multiple sclerosis and of mice with cuprizone-induced demyelination, in ex vivo models of demyelination and in cultured neurons exposed to glutamate and tumor necrosis factor-. Nuclear export of HDAC1 was mediated by the interaction with the nuclear receptor CRM-1 and led to impaired mitochondrial transport. The formation of complexes between exported HDAC1 and members of the kinesin family of motor proteins hindered the interaction with cargo molecules, thereby inhibiting mitochondrial movement and inducing localized beading. This effect was prevented by inhibiting HDAC1 nuclear export with leptomycin B, treating neurons with pharmacological inhibitors of HDAC activity or silencing HDAC1 but not other HDAC isoforms. Together these data identify nuclear export of HDAC1 as a critical event for impaired mitochondrial transport in damaged neurons.
a r t I C l e S Axonal damage has been described in several neurodegenerative disorders 1 and in inflammatory demyelination, such as that of multiple sclerosis [2] [3] [4] . The morphological changes associated with axonal damage include the presence of localized axonal swellings, characterized by the succession of enlargements and constrictions along the axon ('beads-on-a-string' appearance) and the detection of 'ovoids' or 'end bulbs' , resembling the terminal stumps of transected axons 3, 4 . Axonal transections have been considered a hallmark of irreversible axonal degeneration 3, 5 , and the presence of ovoids in the proximal part of the axons is typically associated with rapid retrograde degeneration 6 and neuronal death 7, 8 . These neuropathological findings can be detected in distinct neurodegenerative disorders, which thereby suggests that these pathological conditions might share a similar mechanism of induction of axonal damage.
A marker of axonal damage is immunoreactivity with antibodies for the hypophosphorylated form of neurofilament heavy chain (SMI32). Neurofilaments, axonal cytoskeletal molecules, consist of three subunits classified on the basis of molecular weight: 200-kDa heavy (NFH), 150-kDa medium (NFM) and 68-kDa light (NFL) chains. In physiological conditions, these subunits are phosphorylated and the degree of phosphorylation correlates with axonal caliber and speed of axonal transport 9 , possibly by affecting the association of neurofilaments with the motor protein kinesin 10 . Hypophosphorylated neurofilaments, in contrast, are characterized by enhanced susceptibility to protease digestion 11 , greater tendency to self-aggregate 12 and colocalization with tumor necrosis factor (TNF)-α immunoreactivity 13 , and they are typically detected in the brains of animals used as models of demyelination 14 and of humans with multiple sclerosis 15 .
Although the molecular mechanism linking axonal transport and neuropathology is not well characterized, many studies have reported that disruption of axonal transport 16 results in the rapid accumulation of proteins at the sites of swelling 17 . High concentrations of glutamate in cultured neurons impair neurofilament transport and induce cytoskeletal protein accumulation at the sites of axonal swelling 18 , thereby suggesting a causal relationship between localized swellings and local disruption of axonal transport 19 . Impaired axonal transport is likely to eventually trigger Wallerian degeneration of distal axons, and therefore it can be considered one of the first signs of damage that is associated with localized swelling and ultimately leads to transection.
Several pathological stimuli can impair axonal transport, including accumulation of mutant proteins, cytoskeletal disorganization, excitotoxicity and altered histone deacetylase (HDAC) activity 17, 20 . HDACs are a family of enzymes originally named after their ability to remove acetyl groups from lysine residues located within the N-terminal tails of histones, causing compaction of chromatin and repression of transcription 21, 22 . On the basis of their primary structure, HDACs can be further classified as class I (HDAC1, 2, 3 and 8), class II (HDAC 4, 5, 6, 7 and 9), class III (SIRT1-SIRT7) and class IV (HDAC11) 21 . It has now been shown that HDACs also modulate the activity of nonhistone proteins such as YY1 (ref. 23 ) and NF-κB (ref. 24 ). In addition, class II HDACs are cytosolic enzymes that remove acetyl groups from the epsilon positions of lysine residues of cytosolic proteins, including α-tubulin 25 . The class II HDACs HDAC4 and HDAC5 shuttle in and out of the nucleus. In physiological conditions, they are detected in the cytoplasm 21 . In pathological conditions (for example, in Huntington's disease), however, HDAC5 is detected in the nucleus, where it is thought to repress gene expression 26 . Acetylation of α-tubulin regulated by a a r t I C l e S microtubule-associated deacetylase, HDAC6 (ref. 25) , negatively affects axonal transport by removing acetyl groups from α-tubulin, thereby impairing its ability to recruit the motor proteins kinesin-1 and dynein to microtubules. In agreement with the negative effect of HDAC6 in vesicular transport, this molecule has been noted as a component of Lewy bodies in Parkinson's disease 27 , and in Huntington's disease it has been associated with defective release of neurotrophic factors 28 . The data from these studies suggest that axonal transport is negatively regulated by HDAC6-dependent deacetylation of α-tubulin in neurodegenerative disorders.
Impaired axonal transport has also been correlated with cytoskeletal disorganization caused by the proteolytic degradation of cytoskeletal proteins induced by calcium activated proteases 29 . It has been proposed that excess Ca 2+ activates Ca 2+ -dependent proteases such as calpain and caspases, which act on several substrates, most of which are cytoskeletal proteins 29 . However it is unclear whether calcium entry and HDAC activity are independent mechanisms associated with early and late stages of axonal damage.
This study describes the neuron-specific and calcium-dependent nuclear export of HDAC1 in demyelinating conditions and in neurons exposed to excitotoxic amino acids and cytokines, which we used to mimic the inflammatory environment characteristic of the demyelinated brain 30 . We identify molecular events responsible for morphological changes of neurites that were independent of HDAC6-mediated tubulin deacetylation and dependent on a cytotoxic function of cytosolic HDAC1.
RESULTS

HDAC1 nuclear export in damaged axons
Previous studies reported that the axonal changes detected in humans brains affected by multiple sclerosis can also be observed in the corpus callosum of mice with cuprizone-induced demyelination 14, 31 . Therefore, we processed brain sections from C57BL/6J mice maintained on a 0.2% cuprizone diet for 4 (n = 9) or 6 weeks (n = 6) or on a regular diet (n = 15). To test the hypothesis that histone deacetylases could be involved in axonal damage induced by neuroinflammation, we focused our analysis on callosal axons in the 4-week group, because at this time point we can detect demyelination associated with extensive microglial infiltration and axonal damage 31, 32 . We used antibodies specific for class I and class II HDACs in neurofilament-positive (red) axons (white arrows). Scale bar, 10 µm. (e) Adjacent sections processed for immunohistochemistry with antibodies for SMI32 (red) and HDAC1 (green) in white-matter lesions. DAPI (blue) was used as nuclear counterstain. Scale bar, 10 µm. (f) Confocal images of cerebellar slice cultures either untreated (control) or treated with lysolecithin and LPS to induce demyelination (Lyso/LPS 17 h + LPS 24 h). Cultures were stained with antibodies specific for myelin basic protein (MBP, red) and NFs (green) antibodies. (g) The same cultures were then stained for HDAC1 (green) and SMI32 (red). 1 8 2 VOLUME 13 | NUMBER 2 | fEBRUaRy 2010 nature neurOSCIenCe a r t I C l e S and for neurofilament medium chain to identify callosal axons. We detected no difference in the subcellular localization of class I and II HDAC isoforms in cuprizone-treated and control mice (Fig. 1a) , with the exception of HDAC1, which showed a more prominent cytosolic localization in the corpus callosum of cuprizone-treated mice, especially in areas associated with microglial infiltration (Fig. 1a) and axonal damage (Fig. 1b) . The protein levels for the distinct HDAC isoforms remained unchanged throughout the duration of the cuprizone treatment ( Supplementary Fig. 1 , n = 3 mice per time point). Cytoplasmic HDAC1 was also present in sections from brain blocks that were selected from four people with neuropathologically confirmed multiple sclerosis. Tissues were sampled from the superior frontal gyrus by selecting those blocks containing macroscopically visible lesions. We screened the areas of interest for the presence of demyelination, using Luxol fast blue plus periodic acid Schiff staining (Fig. 1c) , and then evaluated the immunoreactivity of SMI32, an antibody specific for the hypophosphorylated form of neurofilaments heavy chain, in 29 areas of interest within the demyelinated regions. The number of HDAC1 + and SMI32 + HDAC1 + profiles was quantified per ×400 microscopic field (0.29 mm 2 ). No HDAC1 + SMI32 − profiles were noted. The average number of HDAC1 + processes per mm 2 was 7.55 ± 1.8 (mean ± s.e.m.), and the average number of SMI32 + neurites was 29.8 ± 6.1 (mean ± s.e.m.). Thus, we detected colocalization in 25.3% of damaged axons identified by immunoreactivity for SMI32 (Fig. 1d,e) .
We also detected HDAC1 translocation in an ex vivo model of inflammatory demyelination, induced by exposure of cerebellar slice cultures to lysolecithin and lipopolysaccharide (LPS) 33 . Using immunohistochemistry with antibodies specific for NFM-L and for myelin basic protein (MBP) to identify demyelination, we detected multiple beaded axons in demyelinated white matter regions in the presence of activated microglia (Fig. 1f) . These axons were also immunoreactive for HDAC1 and SMI32 (Fig. 1g) , thereby confirming the cytoplasmic localization of HDAC1 at the early stages of axonal damage after demyelination and microglial activation.
HDAC1 nuclear export precedes the onset of axonal damage
It has been previously proposed that glutamate and cytokines produced by microglial cells can be neurotoxic, and therefore we exposed primary neuronal cultures to glutamate and cytokines in order to best mimic the inflammatory environment in the human brain affected by multiple sclerosis 30 . Immunocytochemistry was used to characterize the cellular composition of the neuronal cultures ( Supplementary  Fig. 2a,b) . Increasing concentrations of glutamate together with a constant amount of cytokine (200 ng ml −1 TNF-α) were tested for the ability to induce neurite pathology. We chose the lowest concentration (50 µM glutamate and 200 ng ml −1 TNF-α) that induced neuritic beading within 2 h of exposure to perform a time-course experiment of axonal damage, using immunoreactivity for SMI32 and morphological appearance of beaded neurites as detection criteria. In agreement with the progressive nature of damage, after 2 h, 42.88 ± 8.06% of the neurites showed the characteristic beaded morphology and 20.6 ± 9.46% were also SMI32 + ; after 24 h, 88.07 ± 1.98% showed beading and 61.58 ± 2.23% were SMI32 + (Fig. 2a,b) . To confirm the relationship between localized beading and later signs of damage, we conducted live imaging on neurons before and after treatment with glutamate and TNF-α and followed the morphological changes occurring during the next 12 h, using time-lapse video microscopy. During the first 2 h, we detected a progressive increase in the percentage of beaded neurites, which was later replaced by the detection of transections, a hallmark of late stages of axonal damage (Fig. 2c,d) , and the latter was associated with decreased neuronal viability (Supplementary Fig. 3) .
The progressive nature of the morphological changes detected in the neurites after treatment with glutamate and TNF-α correlated with the progressive changes of HDAC1 subcellular localization. Before exposure to excitotoxic amino acids and cytokines, we detected HDAC1 within the nuclear compartment (Fig. 3a) . However, within the first 5 min of treatment we observed it in a perinuclear location (Fig. 3a) , by 20 min it was evenly distributed along the entire length of the neurites, and at 2 h it formed aggregates within the enlargements of the beaded neurites (Fig. 3a,b) . On the basis of these results, we hypothesized that nuclear export of HDAC1 was part of the mechanism leading to neuronal damage. Previous evidence had suggested that localized enlargements and beading were associated a r t I C l e S with disrupted axonal transport and consequent accumulation of proteins and organelles 16 . Labeling of treated primary cultured neurons with the cell-permeable mitochondrial dye MitoTracker Green FM (Invitrogen) followed by time-lapse video microscopy allowed us to visualize all of moving mitochondria (Fig. 3c) . The average speed of mitochondrial transport in untreated primary neurons was 0.23 ± 0.04 µm s −1 . After 5 min of treatment, when HDAC1 was detected in perisomatic locations but not yet in the neurites, mitochondrial transport was still 0.21 ± 0.07 µm s −1 . At 20 min, however, when HDAC1 reached the neurites, mitochondrial transport was slower (0.089 ± 0.012 µm s −1 ). By 2 h, the average speed had decreased even more (0.038 ± 0.029 µm s −1 ), and this correlated with the detection of localized neurite swellings (Fig. 3d) . Thus, impaired mitochondrial transport preceded the appearance of localized beading.
To address the possibility that the subcellular localization of other HDAC isoforms was similarly affected, we repeated immunocytochemistry in primary neurons, cultured for 2 h in the presence of glutamate and TNF-α, using antibodies specific for each isoform and DAPI as nuclear counterstain ( Supplementary Fig. 4 ). Of all the HDAC members analyzed, HDAC3, HDAC4, HDAC6 and HDAC8 were also detected in the cytoplasm. However, HDAC1 was the only isoform that was exported from the nucleus and accumulated in the neurites in response to glutamate and TNF-α treatment ( Supplementary Fig. 4 ). To further confirm the nuclear export of HDAC1, we repeated the experiment using three distinct HDAC1 antibodies, including two commercially available ones generated against the C terminus and one against the N terminus of the molecule (Supplementary Fig. 5 ). We obtained the same results with all three reagents. Inducible HDAC1 nuclear export was cell-type specific, as it was detected in primary neurons, but not in astrocytes or oligodendrocytes receiving the same treatment ( Supplementary Fig. 6 ). To further validate the inducible nuclear export of HDAC1 using an alternative approach, we expressed a Flag-tagged HDAC1 molecule in neurons and tracked its subcellular localization in response to glutamate and TNF-α treatment, using (Fig. 4a) . Whereas in the absence of any treatment overexpressed Flag-tagged HDAC1 was detected exclusively in the nuclei of transfected neurons, after treatment with glutamate and TNF-α the Flag-tagged HDAC1 was first detected in perinuclear locations and then distributed all along the neurites (Fig. 4b) .
Because axonal damage in demyelinating disorders is not limited to areas of acute demyelination 34 , it has been proposed that damage could be caused by calcium entry in response to distinct causes, including myelin loss 5 , activation of glutamate receptors 35 or cytokine-mediated release from intracellular stores 36 . To determine whether HDAC1 nuclear export was downstream of calcium entry, we pretreated neurons with increasing concentrations of the calcium chelator EDTA for 30 min before exposure to 50 µM glutamate and 200 ng ml −1 TNF-α for 2 h. Cultures were then processed for immunocytochemistry using specific antibodies to HDAC1 and neurofilaments. EDTA pretreatment prevented the onset of neurite beading in a dose-dependent manner, with a maximum effect at a concentration of 10 mM (Fig. 4c) , which correlated with retention of HDAC1 in the nucleus. Thus, HDAC1 nuclear export in response to glutamate and TNF-α treatment required the presence of calcium.
Silencing of HDAC1 prevents neuritic beading
To further define the role of HDAC1 in the induction of neuritic beading, we adopted a silencing approach and tested, for efficiency and specificity of silencing, a minimum of four lentiviral targeting constructs for each HDAC isoform and selected the two most effective ones (Supplementary Fig. 7 ). Primary neurons were transduced with these small hairpin RNAs (shRNAs), and 72 h later they were treated with glutamate and TNF-α. Mock-infected cultures were used as controls (Fig. 5a) . Silencing of Hdac1 prevented the appearance of beaded neurites. Whereas the percentage of beaded neurites in mock-infected neurons was 58.1 ± 1.65% (n = 35 ± 2.8), the silencing of Hdac1 with shRNA decreased the percentage of beaded neurites to 19.4 ± 2.4% (n = 34 ± 2.1).
Silencing of other members of class I (Hdac2, Hdac3 and Hdac8) and class II (Hdac4 and Hdac6) histone deacetylases, in contrast, did not elicit the same effect (Fig. 5b) . Together these results support a critical role for HDAC1 but not other HDAC isoforms in the onset of neurite beading induced by glutamate and TNF-a.
CRM1-dependent HDAC1 export is essential for axonal damage
Because HDAC1 is a nuclear enzyme, we reasoned that it must be exported from the nucleus by a process that is initiated by exposure to pathological stimuli. For class II HDACs, shuttling from the nucleus to the cytoplasm has been attributed to the presence of nuclear export signals (NESs) 21 , which allow binding to the Exportin 1 receptor (CRM1) followed by transport through the nuclear pore. The original consensus sequence for nuclear export and CRM1 binding was identified as LXXXLXXLXL 37 . Amino acid sequence analysis of HDAC1 using the ScanProsite program (Expert Protein Analysis System) revealed the presence of leucinerich motifs (LXXXLXXL or LXXLXL; Fig. 6a ), similar to the NES that was originally described in viral proteins 37 . Therefore, we hypothesized that nuclear export of HDAC1 could be mediated by the interaction between CRM1 and specific leucine residues within the putative NES. To test this hypothesis, protein extracts from neuronal cultures exposed to glutamate and TNF-α for 5 and 20 min were immunoprecipitated with HDAC1 antibodies and analyzed by western blot. A complex between CRM1 and HDAC1 (Fig. 6b) was detected during the first 5 min of treatment, but not at later time points (Fig. 6b) . To further confirm that this interaction a r t I C l e S was mediated by the NES sequence on HDAC1, we generated a C-terminal Flag-tagged point mutant by converting leucine to alanine residues within the putative NES. Overexpression of this mutant HDAC1 interfered with the formation of a complex with CRM1 ( Fig. 6c) , thereby supporting a functional interaction between the putative NES sequence in HDAC1 and CRM1. The functional significance of HDAC1 nuclear export was then tested with leptomycin B (LMB), a pharmacological inhibitor of CRM1-dependent transport 38 . Pretreatment of neurons with increasing concentrations of LMB for 30 min, before exposure to glutamate and TNF-α, prevented HDAC1 export from the nucleus and inhibited neurite beading in a dose-dependent manner (Fig. 6d,e) . Pretreatment of cultured neurons with doses of LMB that prevented HDAC1 nuclear export also affected mitochondrial transport. Whereas an 84% decrease in the speed of mitochondrial transport was detected in cultures exposed to glutamate and TNF-α compared to untreated controls, LMB pretreatment significantly ameliorated the ability of mitochondria to move even in the presence of glutamate and TNF-α, although it was unable to restore the speed to that measured in controls (Fig. 6f,g ). Together these results suggest that CRM1-mediated nuclear export of HDAC1 is part of the mechanism that modulates mitochondrial transport in pathological conditions associated with localized neurite swellings and beading.
Cytosolic binding partners for HDAC1 in damaged axons
Because HDAC1 nuclear export decreases its bioavailability in the nucleus, it is conceivable that impaired mitochondrial transport could be consequent to decreased nuclear function, rather than to acquisition of a cytosolic function. Histone H3 is one of the main nuclear substrates for HDAC1, and therefore we assessed the effect of glutamate and TNF-α treatment on the levels of acetyl-H3 (Supplementary Fig. 8a ) and on the transcript levels of genes previously shown to be regulated by HDAC1 [39] [40] [41] [42] . We did not detect increased acetyl-H3 until 2 h, and we detected no change in the abundance of transcripts involved in apoptosis (Bax and Jun), survival (Bcl2) or axonal damage (Scn2a1, also known as Nav1.2; Scn8a, also known as Nav1.6; and Jun) (Supplementary Fig. 8b ). Because the first localized signs of beading were observed as early as 20 min after exposure to glutamate and TNF-α, well before any change in acetyl-H3 could be measured, we concluded that the effect of HDAC1 nuclear export on neuritic damage was likely due to a cytosolic gain of function rather than loss of its nuclear function.
To mechanistically define the role of cytosolic HDAC1 in axonal damage and find potential binding partners in the axons of damaged neurons, we adopted an unbiased approach and performed MALDI-TOF mass spectrometry on protein extracts isolated from callosal axons of control and cuprizone-treated mice and from untreated or glutamate and TNF-α treated neuronal primary cultures, immunoprecipitated with antibodies to HDAC1. The experiment was independently repeated on three distinct mouse groups and three groups of neuronal cultures. Only molecules that were identified as binding partners in all six independent samples (three in vivo experiments and three in vitro experiments) were further processed for validation analysis, using immunoprecipitation and western blot of protein extracts from the corpus callosum of untreated mice (n = 7) and of mice treated with cuprizone for 4 (n = 7) or 5 weeks (n = 4). The results obtained after immunoprecipitation with anti-HDAC1 were compared with those obtained using anti-HDAC4 and anti-HDAC6 (Fig. 7a) . 
a r t I C l e S
In agreement with previous reports 43 , α-tubulin was a prominent band immunoprecipitated by HDAC6 antibodies in extracts from both control and treated groups (Fig. 7a) . Tubulin was not precipitated by anti-HDAC4 (Fig. 7a) . These data identified differential binding for distinct histone deacetylases to proteins involved in mitochondrial transport (Fig. 7a) . The inducible interaction between HDAC1 and a protein involved in axonal transport (KIF2A) was detected only in brain regions characterized by microglial infiltration and cytokine production (that is, corpus callosum), but was not detected in areas that were not demyelinated (that is, spinal cord) (Fig. 7b) . Previous studies related impaired axonal transport in models of Huntington's disease to deacetylation of α-tubulin mediated by HDAC6, and suggested a positive effect of treatment with HDAC6 inhibitors on axonal transport 28 . In our experimental system, however, the impaired mitochondrial transport was not ameliorated by the presence of a pharmacological inhibitor of HDAC6 (tubacin; Fig. 8a,b) , which increased the acetylation of α-tubulin. These results correlated well with the observation of similar levels of acetyltubulin in control and cuprizone-treated mice (Supplementary Fig. 9a,b ) and in neurons untreated or treated with glutamate and TNF-α (Supplementary Fig. 9c ). Together, these results support the concept that distinct HDAC isoforms are differentially involved in the induction of axonal damage caused by different stimuli.
The detection of cytosolic HDAC1, rather than HDAC6, in response to neuronal exposure to glutamate and cytokines suggested the possibility that HDAC1 inhibitors would improve mitochondrial transport. Indeed, mitochondrial transport in neurons treated with glutamate and TNF-α was significantly better in the presence of the inhibitor MS-275 (Fig. 8a,b ) than in its absence or in the presence of the HDAC6 inhibitor tubacin (Fig. 8a,b) , thereby supporting an Glu/TNF-α a r t I C l e S HDAC1-dependent mechanism of impaired mitochondrial transport. The respective effectiveness of MS-275 and tubacin in modulating mitochondrial transport in neurons treated with glutamate and TNF-α correlated with the protective role of MS-275, but not tubacin, on the induction of neurite beading (Fig. 8c,d) . Thus, whereas HDAC1 inhibitors improved mitochondrial transport and prevented damage, HDAC6 inhibitors did not protect from damage induced by exposure to both glutamate and TNF-α. Because the acetylation status of α-tubulin was not affected by our experimental paradigm, we reasoned that HDAC1 modulation of axonal transport must include the involvement of other binding partners. The most likely candidates were the motor proteins KIF2A and KIF5, which were identified by MALDI-TOF. Therefore, we conducted immunoprecipitation of extracts from neurons, either untreated or treated with glutamate and TNF-α, with antibodies for HDAC1 or HDAC6 and assessed the identity of the binding partners by western blot analysis, using antibodies specific for α-tubulin, for KIF2A, for KIF5 and for the cargo molecule dynamin (Fig. 8e) . As predicted by the in vivo results, the interaction between α-tubulin and HDAC1 was detected only after 20 min of treatment and was coincident with the first detection of impaired mitochondrial transport, whereas the interaction with HDAC6 was constitutive (Fig. 8e) . Notably, there was a switch in the ability of KIF2A to bind distinct isoforms. Whereas in untreated neurons KIF2A was predominantly bound to HDAC6, in treated neurons this interaction was detected primarily with HDAC1 (Fig. 8e) . Finally, while HDAC6 was able to bind dynamin, no interaction was detected between this molecule and HDAC1. These interactions required the specific activity of distinct HDAC isoforms, because only treatment with MS-275, not with tubacin, prevented the interaction of HDAC1 with the motor proteins (Fig. 8e) . Because HDAC1 interacted with motor proteins, but not with dynamin, we asked whether the ability of this protein to bind KIF2A and KIF5 was inversely correlated with HDAC1 binding. Indeed, in untreated neurons, dynamin was found in complex with KIF2A, KIF5 and α-tubulin (Fig. 8f) . Exposure to glutamate and TNF-α disrupted this interaction, despite the constant protein levels of these molecules (Fig. 8g) . Cotreatment with the HDAC1 inhibitor MS-275, in contrast, partially rescued complex formation among KIF2A, KIF5, α-tubulin and dynamin (Fig. 8f) . HDAC1 silencing also restored binding of dynamin with α-tubulin, but only partially restored the interaction with motor proteins (Fig. 8f) . The lack of complete reversion of the effect could be explained by taking into account the efficiency of silencing in primary neurons ( Supplementary  Fig. 7a) or by inferring the existence of additional mechanisms modulating the glutamate-dependent effect on axonal transport. On the basis of these results, we conclude that neuroinflammatory stimuli, including excitatory amino acids and cytokines, induce calcium-dependent HDAC1 nuclear export. Cytosolic HDAC1 binds to α-tubulin and kinesin motors (KIF2A and KIF5) in an activity-dependent fashion, thereby disrupting the formation of functional interactions between these motor proteins and dynamin on cargo (Supplementary Fig. 10 ). The impaired axonal transport, coincident with the areas of aggregation of HDAC1-motor protein complexes, might contribute to localized areas of swelling that eventually lead to irreversible transections. Therefore, the definition of the molecular interactions among motor proteins, dynamin, α-tubulin and HDAC1 is likely to provide a better understanding on how to restore mitochondrial transport and axonal function.
DISCUSSION
Axonal damage detected in inflammatory demyelination, such as multiple sclerosis 2, 3 , has been associated with impaired mitochondrial function 5 and related to calcium entry due to aberrant activation of sodium channels or activation by excitatory amino acids and cytokine production 17, 20 . However the molecular mechanisms linking defective mitochondrial function to calcium entry remained elusive. In this study we identified calcium-mediated nuclear export of HDAC1 as a critical modulator of impaired mitochondrial transport and the induction of axonal damage in inflammatory demyelination. Cytosolic HDAC1 was detected in the brains of humans with multiple sclerosis, in animal models of demyelination characterized by microglial infiltration and cytokine production 14, 31 , and in cultured neurons exposed to excitatory amino acids and cytokines to mimic the inflammatory environment of the brain in multiple sclerosis 30 . Previous studies in other neurodegenerative disorders have focused on the neurotoxic effect of nuclear localization of other isoforms of cytosolic HDACs and suggested that neurotoxicity was the result of HDAC-dependent repression of survival genes 44, 45 . Our results, in contrast, suggest a cytotoxic role for the exported HDAC1 that is independent of its nuclear function and that is part of the mechanism impairing mitochondrial transport and inducing neurite beading in response to excitatory amino acids and cytokines. The neuroprotective effect of treatment with leptomycin B, a pharmacological blocker of CRM1-mediated nuclear export, suggested that the role of HDAC1 in axonal damage required a cytosolic, rather than nuclear, localization. If nuclear export of HDAC1 impaired mitochondrial transport owing to its effect on the transcription of proapoptotic genes, then acetylation of nuclear substrates and changes in gene expression should have kinetics that precede impaired mitochondrial transport. Acetylation of nuclear histones and altered gene expression, to the contrary, were detected only at later stages. Thus, we conclude that axonal damage is mediated by a gain of cytosolic function for HDAC1 rather than loss of a protective nuclear function. The toxic effect of cytosolic HDAC1 on axonal transport is consequent to its ability to bind to motor proteins (KIF2A and KIF5) and α-tubulin, disrupting their ability to form complexes with cargo proteins (such as dynamin). These complexes were detected in demyelinated brain regions in animal models characterized by cytokine production by microglial cells (corpus callosum) and in neurons exposed to glutamate and cytokines, but not in undemyelinated regions (spinal cord) or in untreated cultures.
A role for cytoplasmic HDAC6 in the inhibition of axonal transport had been previously suggested for pathologies characterized by intracellular accumulation of misfolded proteins 28 . This role was attributed to the ability of HDAC6 to deacetylate α-tubulin 25 . Because α-tubulin deacetylation decreases its ability to recruit motor proteins, it was suggested that HDAC6-mediated inhibition of axonal transport decreases the vesicular transport of neurotrophic factors and negatively affects neuronal survival 28 . Our results, however, in a model of axonal damage associated with inflammatory demyelination, suggest a mechanism of impaired axonal transport that is independent of HDAC6. Deacetylation of α-tubulin was not significantly changed in cultured neurons exposed to glutamate and cytokines or in animal models of demyelination. In addition, only silencing of HDAC1 and treatment with a pharmacological inhibitor of HDAC1 activity (MS-275), but not of HDAC6 activity (tubacin), were able to improve mitochondrial transport, prevent the disruption of complexes between cargos and motor proteins and reduce the formation of axonal swellings. We note that the improvement detected in the presence of pharmacological inhibitors or in response to HDAC1 silencing was not a complete reversion of the toxic effect of glutamate and TNF-α treatment. Previous studies have discussed the importance of phosphorylation of motor proteins in disrupting axonal transport 46 . We cannot formally exclude the possibility that some of a r t I C l e S these mechanisms of impaired axonal transport might still occur in the presence of HDAC inhibitors or HDAC1 silencing and be partially responsible for the incomplete rescue.
We suggest that distinct neurological disorders might share the morphological appearance of damage (such as beaded neurites) by differential involvement of distinct HDAC isoforms. In the case of Huntington's disease, impaired transport consequent to α-tubulin deacetylation is mediated by HDAC6, whereas in neuroinflammation impaired transport is caused, at least in part, by HDAC1 nuclear export and sequestration of motor proteins into protein complexes that alter mitochondrial transport.
The concept of cytoplasmic retention of HDAC1 in pathways associated with inflammation is supported by studies in other cellular systems. Although most of the literature focuses on the nuclear role of HDAC1, a few studies in neuroblastoma cells 47, 48 reported the translocation of HDAC1 to the cytoplasm in response to HSV-1 viral infection. In addition, in 293 and HeLa cells, the NF-κB inhibitor IκBα was shown to interact with HDAC1 and HDAC3 and sequester these proteins in the cytoplasm 49 . We therefore conclude that distinct HDAC isoforms have the ability to negatively regulate axonal transport by interrupting the motor protein-microtubule interaction in a context-specific fashion that is dependent on the cell type and on the pathological stimulus. The identification of HDAC1 nuclear export as an event downstream of calcium entry in response to excitatory amino acids and cytokines treatment defines an important molecular target for pathologies associated with inflammation. Future studies on the molecular characterization of the events leading to altered axonal transport might lead to the identification of new therapeutic targets preventing the irreversibility of axonal transection.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Antibodies for immunohistochemistry, immunocytochemistry and western blot. We used the following antibodies: neurofilament medium chain (Upstate; Chemicon), 1:300 for immunohistochemistry (IHC) and immunocytochemistry (ICC); neurofilament light chain (Abcam), 1:300 for ICC; α-tubulin, 1:10,000 for western blot, and acetylated-α-tubulin, 1:10,000 for western blot (both Sigma); CNPase, 1:1,000 for western blot; non-phosphorylated neurofilaments, 1:20,000 for ICC, 1:500 for IHC on human sections; MBP, 1:1,000 for ICC; GFAP, 1:1,000 for ICC (all Sternberger Monoclonal); KIF2A (Abcam), 1:20,000-40,000 for western blot; HDAC1 (Affinity BioReagents), 1:4,000 for ICC and western blot; HDAC1, 1:100 for IHC and ICC, 1:500 for western blot; HDAC2, 1:100 for IHC, 1:1,000 for western blot; anti-HDAC3, 1:200 for ICC, 1:1,000 for western blot; HDAC4, 1:200 for ICC, 1:1,000 for western blot; HDAC5, 1:1,000 for western blot; HDAC6, 1:50 to 1:200 for IHC and 1:200 for western blot; HDAC7, 1:1,000 for western blot; HDAC8, 1:50 for IHC (all Santa Cruz Biotechnology); HDAC3 (Abcam), 1:1,000 for IHC; HDAC4 (Upstate), 1:100 for IHC; HDAC5 (Cell Signaling), 1:100 for IHC; HDAC7 (Cell Signaling), 1:100 for IHC; Flag (Sigma), 1:1,000 for ICC and western blot; CRM1 (BD Transduction Lab), 1:1,000 for western blot; dynamin (Abcam), 1:2,000 for western blot; KIF5 (Abcam), 1:2,000 for western blot; Tuj1 (Covance), 1:1,000 for ICC; histone H3 (Abcam), 1:2,000 for western blot; acetyl-histone H3 (Upstate), 1:5,000 for western blot; O4 hybridoma supernatant, 1:10; GFP (Chemicon), 1:1,000 for ICC.
In vivo model of demyelination. For details regarding the cuprizone model of demyelination, please refer to previous papers 31, 32 . Mice were maintained in sterile, pathogen-free conditions under the Institutional Animal Care and Use Committee of Robert Wood Johnson Medical School/University of Medicine and Dentistry of New Jersey and Mount Sinai School of Medicine. For immunohistochemistry, mice were perfused with 4% (wt/vol) paraformaldehyde (PFA) in 0.1 M phosphate buffer and the brains maintained in 30% (wt/vol) sucrose. For RNA or protein extracts, the region of the corpus callosum was dissected and frozen.
Primary cultures. Primary oligodendrocytes and astrocytes were cultured from postnatal day 1 rat pups as described previously 31 . Hippocampi and cortices were dissected from E18 rat or mouse embryos in Hanks' balanced salt solution (HBSS) (Gibco). After digestion with 0.025% trypsin-EDTA for 20 min at 37 °C, cells were incubated with NM10 medium: DMEM (Gibco) with 10% (vol/vol) FBS (Gibco) for 5 min at 25 °C. Cells were then resuspended in neuronal culture medium: Neurobasal supplemented with B27, 10 mM GlutaMax (all Gibco) and 1% penicillin-streptomycin (Sigma). After mechanical dissociation through a pipette, followed by passing into a 22-gauge, 1½-inch syringe, cells were filtered through a cell strainer (BD Falcon) and maintained at 37 °C in a 5% CO 2 incubator. Three days after plating, 5 nM Ara-C (Sigma) was added to the culture medium to avoid glial contamination. The next day, cells were fed with fresh neuronal medium and incubated 11-12 d more at 37 °C in a 5% CO 2 incubator. Treatments with mouse TNF-α (Chemicon), glutamate (Sigma), EDTA (Sigma), leptomycin B (Sigma), MS-275 (from E. Nestler) and tubacin (a gift from S. Schreiber) were performed at the concentrations indicated in the text. After fixing cells with 1% (wt/vol) PFA for 20 min at 25 °C, cells were postfixed with 100% methanol for 5 min at −20 °C. cerebellar slice cultures. Slice cultures were obtained by dissecting postnatal day 10 cerebella from C57BL/6J mice and cutting them into 400-µm slices using a tissue chopper (SD Instruments). Slices were placed on collagen-coated Millicell-CM culture inserts (Millipore) and grown in medium containing 50% (vol/vol) basal medium with Earle's salts, 25% (vol/vol) HBSS, 25% (vol/vol) horse serum (all Gibco), 5 mg ml −1 glucose and 1% (vol/vol) penicillin-streptomycin stock solution (10,000 units ml -1 and 10,000 mg ml -1 , respectively), in a 5% CO 2 incubator. Demyelination was induced after 10 d in culture by adding 0.5 mg ml −1 lysolecithin and 200 ng ml −1 LPS (both from Sigma) to the medium for 15-17 h. The next day, the medium was replaced with fresh medium containing 200 ng ml −1 LPS for 24 h more. Slices were fixed with 1% PFA, postfixed in −20 °C 100% methanol and then processed for immunostaining.
time-lapse video microscopy. For the time-lapse imaging of fluorescently labeled mitochondria, primary neurons were plated at a density of 2.5 × 10 5 into 35-mm coverglass-bottom dishes (Willco Wells) or 3 × 10 4 into eight-well coverglass-bottom slides (Nunc) and maintained for 14 d in neuronal culture medium. Mitochondria were labeled with 20 nM of the lipophilic mitochondrial dye MitoTracker (Invitrogen) for 30 min at 37 °C. The medium was then replaced with fresh neuronal culture medium without phenol red (Gibco) supplemented with 50 µM glutamate and 200 ng ml −1 TNF-α. At each time point as indicated in the figures, live cell images were captured every 5 s for 5 min using the AxioObserver.Z1 inverted fluorescence microscope equipped with a controlled humidity, temperature and CO 2 incubation system (Carl Zeiss MicroImaging). A ×63 oil immersion objective was used to acquire images. Analysis of mitochondrial movement was performed using ImageJ (US National Institutes of Health) and the AxioVision Rel.4.7 program (Carl Zeiss MicroImaging).
To examine the relationship between morphological changes and progression of axonal damage, we used differential interference contrast imaging. Images were captured every 20-30 min for 12-16 h using AxioObserver.Z1 (Zeiss).
Immunohistochemistry and immunocytochemistry.
Immunohistochemistry and immunocytochemistry were performed as described previously 31 . Immunoreactive cells were visualized using confocal microscopy (LSM510 or LSM710 Meta confocal laser scanning microscope; Carl Zeiss MicroImaging). Fixed frozen tissue blocks from three controls and four individuals with secondary progressive multiple sclerosis from the UK multiple sclerosis brain bank were processed for Luxol fast blue plus periodic acid Schiff staining to identify areas of white matter demyelination. The same sections were also stained with antibodies to HDAC1, SMI32 and HDAC6, after citrate buffer microwave retrieval, and directly bound secondary conjugates (Alexa Fluor 488-goat anti-rabbit, Alexa Fluor 546-goat anti-mouse). Twenty-nine areas of interest from five lesion-containing tissue blocks from four individuals with multiple sclerosis were scrutinized for HDAC1, HDAC6 and SMI32 immunoreactivity.
Silencing experiments. For efficiency and specificity of silencing, 4 × 10 4 hippocampal neurons were plated in eight-well chamber slides (Nunc) and cultured for 10-11 d at 37 °C, 5% CO 2 incubator. Infection with the Mission TurboGFP shRNA control transduction particles (Sigma) was conducted at multiplicity of infection = 20, in the presence of 4 µg ml −1 hexamethrine bromide (Sigma) at 37 °C for 2 h. Cultures were then maintained in medium for 72 h at 37 °C, 5% CO 2 incubator. Infection efficiency was assayed by immunocytochemistry, using antibodies to GFP and NFs. The percentage of infected cells was calculated as the number of GFP + cells divided by the total number of DAPI nuclei per field.
For immunocytochemistry (4 × 10 4 hippocampal neurons in eight-well chamber slides), quantitative PCR (3 × 10 5 hippocampal neurons in six-well plates) and immunoprecipitation (2 × 10 6 cortical neurons in 15-cm dishes), primary neurons were cultured for 10-11 d and then infected with lentiviral shRNA constructs from Sigma (Mission shRNA). For each isoform, four shRNA constructs were tested, and only those achieving more than 50% reduction of target are listed below. For Hdac1, shRNA no. 399, 5′-CCGGGCTTGGGTAATAGCAGC CATTCTCGAGAATGGCTGCTATTACCCAAGCTTTTTG-3′; and shRNA no. 401, 5′-CCGGCCCTACAATGACTACTTTGAACTCGAGTTCAAAGTAGTCA TTGTAGGGTTTTTG-3′. For Hdac2, shRNA no. 396, 5′-CCGGGCTGTGAA ATTAAACCGGCAACTCGAGTTGCCGGTTTAATTTCACAGCTTTTTG-3′. For Hdac3, shRNA no. 389, 5′-CCGGCGTGGCTCTCTGAAACCTTAACTCG AGTTAAGGTTTCAGAGAGCCACGTTTTTG-3′. For Hdac4, shRNA no. 253, 5′-CCGGACTCTCTGATTGAGGCGCAAACTCGAGTTTGCGCCTCAATCAG AGAGTTTTTTG-3′. For Hdac6, shRNA no. 416, 5′-CCGGCCTGGGAAAGAAT CTACTCTACTCGAGTAGAGTAGATTCTTTCC-3′. For Hdac8, shRNA no. 001, 5′-CCGGGTGGATTTGGATCTACACCATCTCGAGATGGTGTAGATCCAAAT CCACTTTTTG-3′ (all from Sigma). Neurons were infected with Mission shRNA lentiviral particles (multiplicity of infection = 20) in the presence of 4 µg ml −1 hexamethrine bromide (Sigma). Mock-infected controls consisted of neuronal cultures incubated with 4 µg ml −1 hexamethrine bromide. Cells were treated with 50 µM glutamate and 200 ng ml −1 TNF-α for 20 min or 2 h and then processed for immunocytochemistry, quantitative PCR or immunoprecipitation.
transfection. Hippocampal neurons (4 × 10 4 ) were plated in eight-well chamber slides and cultured in neuronal culture medium for 11-12 d at 37 °C in a 5% CO 2 incubator. The cultures were transfected with C-terminal Flag-tagged HDAC isoforms in the pBJ5 mammalian expression vector (a gift from S. Schreiber) using
